bioRxivMicrobiologyPreprint
PSGL-1 excludes HIV Env from virion surface through spatial hindrance involving structural folding of the decameric repeats (DR)
Sameer Tiwari, Bryan M. Delfing, Han YangiD, Christopher LockhartiD, Amrita Haikerwal, Abdul A. WaheediD, Eric O. FreediD, Mohsin Saleet JafriiD, Dmitri K. KlimoviD, Yuntao WuiD
Abstract
P-selectin glycoprotein ligand-1 (PSGL-1), a mucin-like surface glycoprotein, is primarily expressed on lymphoid and myeloid cells. PSGL-1 has recently been identified as an HIV restriction factor, blocking HIV infectivity mainly through virion incorporation that sterically hinders virion attachment to target cells. PSGL-1 also inhibits HIV Env incorporation into virions. However, the molecular mechanisms of PSGL-1-mediated Env exclusion remained unclear. Here, we investigated the role of PSGL-1s extracellular (EC) and intracellular (IC) domains in Env exclusion. We demonstrate that both EC and IC are important for Env exclusion; when EC was deleted, PSGL-1 completely lost its ability to inhibit Env incorporation, whereas when IC was deleted, PSGL-1 partially lost this activity. In addition, when the decameric repeats (DR) were deleted from EC, PSGL-1 also lost its ability to inhibit Env incorporation. Sequential DR deletion mutagenesis further demonstrated that a minimum of 9 DRs is necessary for Env exclusion. Molecular modeling of the DR structure revealed that PSGL-1 mutants with 7 or fewer DRs pose as an extended "rod-like" structure, whereas those with 9 or more DRs collapse into a "coil-like" structure that spatially excludes Env. Our studies suggest a model in which Env exclusion involves Gag-mediated PSGL-1 targeting to the virion assembly site where DR-mediated spatial exclusion blocks Env incorporation.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The decameric repeat (DR) of PSGL-1 functions as a basic antiviral unit in restricting HIV-1 infectivity
Han Yang, Leanna Sealey, … Yuntao Wu·bioRxiv·May 14, 2025
- PSGL-1 inhibits HIV-1 infection by restricting actin dynamics and sequestering HIV envelope proteins
- The P-selectin ligand PSGL-1 (CD162) is efficiently incorporated by primary HIV-1 isolates and can facilitate trans-infection
J. Burnie, A. T. Persaud, … C. Guzzo·bioRxiv·Jun 29, 2021
- Identification of the SHREK family of proteins as broad-spectrum host antiviral factors
D. Dabbagh, S. He, … Y. Wu·bioRxiv·Feb 2, 2021
- PIP2 promotes the incorporation of CD43, PSGL-1 and CD44 into nascent HIV-1 particles
Ricardo de Souza Cardoso, Tomoyuki Murakami, … Akira Ono·Science AdvancesPeer-reviewed·Apr 4, 2025
- IFN-inducible Human Phospholipid Scramblase 1 (PLSCR1) ProteinRestricts HIV-1 Infection by Inhibiting Membrane Fusion
Yajie Liu, Pei Li, … Shan‐Lu Liu·Proceedings of the National Academy of SciencesPeer-reviewed·Sep 26, 2025